Gates gives Selecta $1.25M for malaria vax; Protein Sciences extends contract for Flublok;

> The Bill & Melinda Gates Foundation has granted Selecta Biosciences $1.25 million to advance work on a new malaria vaccine. Story

> Protein Sciences has extended its contract with BARDA, grabbing $50.6 million to support development, scale-up and expanded licensure of flu vaccines Flublok and Panblok. Release

> Vietnam will add pneumonia, diarrhea and HPV vaccines to its subsidized national program. Story

> AmVac has initiated a Phase III trial of lead vaccine Gynevac for bacterial vaginosis. Release

> PsiOxus Therapeutics has initiated a Phase I/II trial to test its oncolytic vaccine enadenotucirev in ovarian cancer patients. Release

> Jack Marsh has resigned from Novavax' ($NVAX) board of directors and will become director emeritus. Release

> TapImmune ($TPIV) has appointed Dr. Keith Knutson to chair its scientific advisory board. Release

And Finally... Czech scientists have developed a new vaccine against Lyme disease that's ready to use on animals and could be available for humans in the future. Story